Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

OXFORD DRUG DESIGN LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of OXFORD DRUG DESIGN LIMITED

According to OXFORD DRUG DESIGN LIMITED latest financial report submitted on 2023-12-31, the company has a Cash of £543,456.00, Working-Capital of £768,228.00. Compared with the previous year, the company reported a Cash increase of 72.03%, which is an equivalent of -391456. At the same time, the Working-Capital went up by 91.57%, or by -703429.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    -

  • Consolidated A/cs

    N

  • Working Capital

    £ 768228

EBITDA

OXFORD DRUG DESIGN LIMITED Business Credit Report

A Business Credit Report for OXFORD DRUG DESIGN LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for OXFORD DRUG DESIGN LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

OXFORD DRUG DESIGN LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

OXFORD DRUG DESIGN LIMITED Directors and key executives

OXFORD DRUG DESIGN LIMITED currently employs 7 people. Compared with the previous year, the company has reported a staff decrease of 12%, which is an equivalent of 1 employees.
In order to view contact information, including emails and phone numbers for all the employees working at OXFORD DRUG DESIGN LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

7

88%

1y growth

89%

2y growth

Management Level


36

Top

55

Middle

Employee Job Title Email Phone Country
Paul Finn Director
*********@inhibox.com
- GB
Alan Roth Director
*********@inhibox.com
- GB
Grace Edmund Senior Computational Chemist
************@oxforddrugdesign.com
- GB
Alan Roth Chief Executive Officer
*********@oxforddrugdesign.com
- GB
Paul Finn Chief Scientific Officer
*********@oxforddrugdesign.com
- GB

Get direct emails & phone numbers for senior executives working at «OXFORD DRUG DESIGN LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

OXFORD DRUG DESIGN LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

OXFORD DRUG DESIGN LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at OXFORD DRUG DESIGN LIMITED. One of of major shareholders of OXFORD DRUG DESIGN LIMITED is ROY NOMINEES LIMITED, which owns 1071 ORDINARY shares, with a total value of 1,071 None and VIDACOS NOMINEES LIMITED, which owns 500 ORDINARY shares, with a total value of 500 None and NIGEL JONES, which owns 377601 ORDINARY shares, with a total value of 377,601 None and JONATHAN MILNER, which owns 9857143 ORDINARY shares, with a total value of 9,857,143 None and DAVID FORD, which owns 1142857 ORDINARY shares, with a total value of 1,142,857 None.


Name Quantity Share Type Value
ROY NOMINEES LIMITED
1071 ORDINARY 1071 GBP
VIDACOS NOMINEES LIMITED
500 ORDINARY 500 GBP
NIGEL JONES
377601 ORDINARY 377601 GBP
JONATHAN MILNER
9857143 ORDINARY 9857143 GBP
DAVID FORD
1142857 ORDINARY 1142857 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

OXFORD DRUG DESIGN LIMITED competitors:

Top 5 similar companies of OXFORD DRUG DESIGN LIMITED are AURELIA BIOSCIENCE LTD, XENOGESIS LIMITED, IG INNOVATIONS LIMITED, TIZIANA LIFE SCIENCES LIMITED, GAMMADELTA THERAPEUTICS LTD. View and export all the competitor list of OXFORD DRUG DESIGN LIMITED by upgrading your account here.


AURELIA BIOSCIENCE LTD


Revenue
-
Age
14 years
Employees
9
Industry
View Scientific & Education
Website
View https://aure***********

XENOGESIS LIMITED


Revenue
-
Age
14 years
Employees
4
Industry
View Government
Website
View https://xeno**********

IG INNOVATIONS LIMITED


Revenue
155,000.0
Age
15 years
Employees
5
Industry
View Scientific & Education
Website
View http://ig-innov*************

TIZIANA LIFE SCIENCES LIMITED


Revenue
-
Age
27 years
Employees
9
Industry
View Scientific & Education
Website
View http://tizianalifesci********************

GAMMADELTA THERAPEUTICS LTD


Revenue
35,763,895.0
Age
9 years
Employees
5
Industry
View Scientific & Education
Website
View http://gammad***********

View & Export OXFORD DRUG DESIGN LIMITED competitors:

Get the complete list with detailed profiles

Start For Free

OXFORD DRUG DESIGN LIMITED news & activities:


Employees

OXFORD DRUG DESIGN LIMITED number of employees has decreased by -12% compared with previous year and now represents a total number of 7.

uk.globaldatabase.com

2022-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding OXFORD DRUG DESIGN LIMITED


Where is OXFORD DRUG DESIGN LIMITED registered office?

OXFORD DRUG DESIGN LIMITED is located at Oxford Centre For Innovation Blue Boar Court 9 Alfred Street, United Kingdom.

How can I contact OXFORD DRUG DESIGN LIMITED?

You can call OXFORD DRUG DESIGN LIMITED at the following number +441865******

What is the website of OXFORD DRUG DESIGN LIMITED?

OXFORD DRUG DESIGN LIMITED website is https://oxforddrugdesign.com/

How many people work at OXFORD DRUG DESIGN LIMITED?

According to the latest account statement, there are currently 7 of employees working for OXFORD DRUG DESIGN LIMITED.

What is the Business Credit Score of OXFORD DRUG DESIGN LIMITED and how reliable is the company?

In order to check the business credit score of OXFORD DRUG DESIGN LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does OXFORD DRUG DESIGN LIMITED pay their invoices on time?

By requesting a Business Credit Report for OXFORD DRUG DESIGN LIMITED, you will be able to gain more insights about the OXFORD DRUG DESIGN LIMITED payment trends.

Who is the Ultimate Parent of the OXFORD DRUG DESIGN LIMITED?

Information about the ultimate beneficial ownership OXFORD DRUG DE************ of OXFORD DRUG DESIGN LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action